Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tempest Therapeutics (TPST)
NASDAQ:TPST
RESEARCH TOOLSreports
Tempest Therapeutics (TPST) Stock Price & Analysis
511 Followers
TPST Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.17 - $9.77
Previous Close$7.17
Volume66.09M
Average Volume (3M)7.71M
Market Cap
$95.53M
Enterprise Value$99.41M
Total Cash (Recent Filing)$17.60M
Total Debt (Recent Filing)$21.48M
Price to Earnings (P/E)-2.7
Beta2.62
Next Earnings
Mar 26, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.61
Shares Outstanding13,324,065
10 Day Avg. Volume48,465,839
30 Day Avg. Volume7,712,631
Standard Deviation0.25
R-Squared0.05
Alpha-0.07
Financial Highlights & Ratios
Price to Book (P/B)9.68
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-4.39
Forecast
1Y Price Target
$47.00Price Target Upside555.51% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Tempest Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TPST FAQ
What was Tempest Therapeutics’s price range in the past 12 months?
Tempest Therapeutics lowest stock price was $0.17 and its highest was $9.77 in the past 12 months.
What is Tempest Therapeutics’s market cap?
Currently, no data Available
When is Tempest Therapeutics’s upcoming earnings report date?
Tempest Therapeutics’s upcoming earnings report date is Mar 26, 2024 which is in 160 days.
How were Tempest Therapeutics’s earnings last quarter?
Tempest Therapeutics released its earnings results on Aug 10, 2023. The company reported -$0.54 earnings per share for the quarter, missing the consensus estimate of -$0.518 by -$0.022.
Is Tempest Therapeutics overvalued?
According to Wall Street analysts Tempest Therapeutics’s price is currently Undervalued.
Does Tempest Therapeutics pay dividends?
Tempest Therapeutics does not currently pay dividends.
What is Tempest Therapeutics’s EPS estimate?
Tempest Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tempest Therapeutics have?
Tempest Therapeutics has 13,324,065 shares outstanding.
What happened to Tempest Therapeutics’s price movement after its last earnings report?
Tempest Therapeutics reported an EPS of -$0.54 in its last earnings report, missing expectations of -$0.518. Following the earnings report the stock price went up 1.639%.
Which hedge fund is a major shareholder of Tempest Therapeutics?
Currently, no hedge funds are holding shares in TPST
---
Tempest Therapeutics Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$47.00 (555.51% Upside)
$47.00 (555.51% Upside)
Blogger Sentiment
Bullish
TPST Sentiment 83%
Sector Average 68%
Sector Average 68%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
365.58%
12-Months-Change
Fundamentals
Return on Equity
-166.57%
Trailing 12-Months
Asset Growth
-56.91%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Tempest Therapeutics
Millendo Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in the development of novel treatments for endocrine diseases. Its products include livoletide and nevanimibe. The company was founded in April, 2011 and is headquartered in Ann Arbor, MI.
---
Top 5 ETFs holding TPST
Vanguard Total Stock Market ETF
$17.52K
iShares Core S&P Total U.S. Stock Market ETF
$320.32
Up to five ETFs with an Outperform Smart Score that hold TPST. The ETFs are listed according to market value of TPST within the ETF
---